This article explores the 20 stocks insiders were buying in Q1 2025. Previously, we covered the 20 most expensive stocks insiders are dumping in March.
About 30 minutes before the market closed Monday, the broader market index was up 0.3%, while the blue-chip companies gained 0.9%. Meanwhile, the Nasdaq Composite dropped 0.5%. Some stocks were recovering from Friday losses after inflation data came in higher than expected, coupled with weak consumer sentiment, which heightened concerns about the U.S. economy’s stability, according to Investopedia.
As investors react to daily market changes, ongoing uncertainty continues to affect the market. During such times, insider trading often garners attention, as executive purchases of company stock can signal optimism about the company’s prospects. However, insider sales do not always indicate a lack of confidence—they may be influenced by personal financial reasons or a need for diversification. Executives often follow pre-arranged plans, like 10b5-1, to ensure transparency. While insider trading can offer valuable insights, it should be considered alongside a company’s financial health, market conditions, and industry shifts.
An executive wearing a suit striding confidently across a trading floor.
Our Methodology
What are some of the stocks insiders have been buying the most in the first quarter of the year? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least five insiders had purchased shares in January, February, and March. From there, we ranked the 20 stocks with the highest number of insiders purchasing shares.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
With each stock, we note the average price per share of these purchases and the stock’s market capitalization. Let’s take a look at the 20 stocks insiders were buying in Q1 2025.
20. Curtiss-Wright Corporation (NYSE:CW)
Market Cap: $11.941 billion
Number of insiders buying: 7
Curtiss-Wright Corp. provides engineered solutions for the aerospace, defense, and industrial sectors through three segments: defense electronics, aerospace & industrial, and naval & power. The Davidson, North Carolina-based company designs and manufactures products like power management systems, avionics, and coolant pumps, and offers maintenance services for the U.S. Navy and nuclear power plants.
In January, seven insiders, including the CEO, CFO, and COO, acquired approximately $68,731 worth of Curtiss-Wright shares at an average price of $304.12 per share. Currently, the stock is trading at $317.42 per share, having lost 10.55% since the beginning of the year. However, over the past 12 months, its shares have returned 23.54% to its investors.
For the year ended December 31, 2024, the company reported sales of $3.1 billion, up from $2.85 billion in 2023. Operating income totaled $529 million, compared to $484 million in the previous year.
On February 5, the company’s board of directors declared a quarterly dividend of $0.21 per share on Curtiss-Wright common stock. The average price target suggests a potential upside of 21.77% from the latest price.
19. Flowco Holdings Inc. (NYSE:FLOC)
Market Cap: $2.35 billion
Number of insiders buying: 7
Flowco Holdings provides production optimization and methane mitigation solutions for oil and gas operators. The company operates in two segments: Production Solutions and Natural Gas Technologies, offering services like renting, servicing, and selling gas lifts and methane abatement technologies. It also provides digital solutions and manufactures vapor recovery and natural gas systems. The Houston, Texas-based company was founded in 2024 and went public in January 2025.
In January and March, six insiders, including the President and CEO, and CFO, bought a total of approximately $2.13 million worth of Flowco shares at an average price of $24.03 per share. Since the company’s initial public offering in January, the stock has gained 12.46% and is currently trading at $26.00.
For the full year of 2024, Flowco reported revenues of $733.3 million, a 10% increase from $655.3 million in 2023. Net income amounted to $80.25 million, compared to $58.09 million in the prior year.
Six Wall Street analysts rate Flowco Holdings as “Strong Buy” with an average price target of $33.80, according to TipRanks. The average price target represents a 30.00% upside from the latest price.
18. iBio, Inc. Common Stock (NASDAQ:IBIO)
Market Cap: $40.68 million
Number of insiders buying: 7
iBio is a biotechnology firm that leverages AI and advanced computational biology to develop biopharmaceuticals targeting cardiometabolic diseases, obesity, cancer, and other challenging conditions. The San Diego, California-based company uses proprietary 3D modeling and innovative drug discovery platforms to build a pipeline of novel antibody treatments for unmet medical needs. It is also one of the 12 best biotech penny stocks to invest in.
For the second quarter of fiscal 2025, iBio reported $200,000 in revenue and a net loss of $4.36 million, compared to a net loss of $4.49 million in the same period last year.
Earlier this year, iBio announced a collaboration with AstralBio Inc. to develop an antibody that targets Activin E, a potential treatment for cardiometabolic disorders and obesity, using iBio’s proprietary Machine-Learning Antibody Engine.
In January, seven insiders, including the company’s CFO, acquired approximately $654,995 worth of iBio shares at an average price of $2.72 per share. Year-to-date, the stock gained 59.59%, trading at $3.91 per share. Over the past 12 months, iBio shares rose 16.72%.
Based on the estimates of three analysts, iBio stock is a ‘Strong Buy’ with a price target of $4.87. The average price target suggests a 27.49% upside from the latest price.
17. Lakeland Industries, Inc. (NASDAQ:LAKE)
Market Cap: $192.44 million
Number of insiders buying: 7
Lakeland Industries is a global manufacturer of protective clothing for industries, healthcare, and first responders. The company provides a wide range of protective gear for sectors like automotive, construction, healthcare, and government agencies, including law enforcement and the Department of Defense. In December, Lakeland acquired Veridian, a firefighter apparel provider, in an all-cash deal valued at $25 million.
In January, seven insiders, including the company’s president and CEO, and CFO, purchased approximately $297,174 worth of Lakeland shares at an average price of $22.18 per share. Year-to-date, the stock is down 20.92%, trading at $20.20 per share. However, over the past 12 months, Lakeland shares returned 13.38% to its investors.
In February, the company’s board of directors declared a cash dividend for its fiscal first quarter of 2026 of $0.03 per share.
Four analysts rate Lakeland stock as a “Buy” with a price target of $28.25, reports MarketBeat. The average price target suggests a 39.47% upside from the latest price.
16. Martin Midstream Partners L.P. (NASDAQ:MMLP)
Market Cap: $139.04 million
Number of insiders buying: 7
Martin Midstream provides services for petroleum products and by-products in the U.S., including terminalling, processing, storage, and transportation. The Kilgore, Texas-based company operates across four segments: Terminalling and Storage, Transportation, Sulfur Services, and Specialty Products, and owns various terminal facilities. It also processes and transports sulfur and natural gas liquids, serving industries like oil and gas, petrochemicals, and chemicals.
In February and March, seven insiders, including the company’s president and CEO, purchased around $928,354 worth of Martin Midstream shares at an average price of $3.59 per share. Year-to-date, the stock is down 1.67% trading at $3.53 per share. Over the past 12 months, Martin Midstream shares returned 38.98% to its investors.
For the full year 2024, Martin Midstream reported revenues of $707.62 million, which compares to $797.96 million in 2023. Net loss amounted to $5.21 million, compared to net loss of $4.55 million in the prior year.
One analyst rates Martin Midstream stock as “Hold” with a price target of $4.00, according to TipRanks. The average price target suggests a potential upside of 13.96% from the latest price.
15. The York Water Company (NASDAQ:YORW)
Market Cap: $498.74 million
Number of insiders buying: 7
York Water Company, which provides water and wastewater services in Pennsylvania, ranks 15th among the 20 stocks that insiders were buying in the first quarter of 2025. It operates multiple wastewater collection systems, reservoirs, and pipelines, serving industries and municipalities across four counties. The company impounds and distributes drinking water with a focus on maintaining high-quality service.
In January, the company’s management announced a quarterly dividend of $0.2192 per share, marking its 617th consecutive payout. With a history of paying dividends for over 209 years, the company proudly claims to hold the longest streak of consecutive dividends in the United States.
During the first quarter, seven insiders, including the CEO, and CFO, bought approximately $13,145 worth of The York Water Company shares at an average price of $31.46 per share. Year-to-date, the stock is up 6.51%, trading at $34.85. Over the past 12 months, the York Water Company lost 2.65%.
For the full 2024, The York Water Company disclosed a net income of $20.33 million, which compares to a net income of $23.76 million in 2023. Operating revenues amounted to $74.96 million, compared to $71.03 million in the prior year.
In December, The York Water Company completed the acquisition of two water systems, one located in York and the other in Adams County. Additionally, the company acquired the water distribution system at the Brookhaven Mobile Home Community in Hallam Township, York County.
The consensus rating on The York Water Company stock from six analysts is “Buy,” reports StockAnalysis. The average price target suggests a 75.03% upside from the latest price.
14. Ziff Davis, Inc. (NASDAQ:ZD)
Market Cap: $1.64 billion
Number of insiders buying: 7
Ziff Davis is a digital media and internet company, founded in 1927, that owns a variety of technology, health, gaming, and entertainment brands. Its portfolio includes popular platforms like PCMag, CNET, Mashable, RetailMeNot, and IGN, along with health-focused brands such as Everyday Health and BabyCenter. The company, formerly known as j2 Global, rebranded to Ziff Davis in 2021 and is headquartered in New York. It is also one of the 10 best marketing stocks to buy right now.
For the full 2024, Ziff Davis reported revenue of $1.40 billion, up 2.8% year-over-year from $1.36 billion. Net income increased 51.9% to $63.0 million compared to $41.5 million for 2023. Adjusted EBITDA amounted to $493.5 million, compared to $482.3 million in 2023.
In February and March, seven insiders, including the CEO, and CFO, acquired approximately $773,999 worth of Ziff Davis shares at an average price of $39.19 per share. Since the beginning of the year, the stock dropped 31.04%, and currently trades at $37.47 per share. Over the past 12 months, its shares lost 40.00%.
According to six analysts’ estimates, Ziff Davis stock is a “Moderate Buy,” reports MarketBeat. The average price target suggests a 75.27% upside from the latest price.
13. Columbus McKinnon Corporation (NASDAQ:CMCO)
Market Cap: $487.56 million
Number of insiders buying: 8
Columbus McKinnon Corporation designs and manufactures motion solutions for material handling, lifting, and positioning worldwide. The Charlotte, North Carolina-headquartered company offers a wide range of products, including hoists, cranes, conveyors, lifting devices, and motion control systems, serving industries like aerospace, energy, and food production.
In February and March, eight insiders, including the president and CEO, bought around $1.10 million worth of Columbus McKinnon shares at an average price of $17.99 per share. Year-to-date the stock is down 55.97%, trading at $16.40 per share. Over the past 12 months, its shares declined 61.96%.
For the third quarter of fiscal 2025, Columbus McKinnon reported net sales of $234.1 million, compared to $254.1 million in the same period of fiscal 2024. Gross profit amounted to $82.1 million, which compares to $93.9 million in the corresponding quarter of the prior year. During the reporting quarter, the company repaid $15 million of debt.
According to StockAnalysis, two analysts rate Columbus McKinnon as “Buy” with a price target of $44.00. The average price target indicates a 169.28% upside from the latest price.
12. F & M Bank Corp. (OTCQX:FMBM)
Market Cap: $66.89 million
Number of insiders buying: 8
F & M Bank is the parent company of Farmers & Merchants Bank, providing financial services to individuals and businesses in Virginia. The bank offers various deposit accounts, loans, insurance products, and brokerage services, including mortgages, personal and business loans, and credit cards.
For the full year 2024, F & M Bank reported net income of $7.3 million or $2.07 per share, up 163% from net income of $2.8 million or $0.80 per share for 2023. On December 31, 2024, the Company had total assets of $1.30 billion, total loans of $839.9 million, and total deposits of $1.20 billion. This reflects growth of $17.9 million, or 2%, in total loans and $61.9 million, or 5%, in total deposits since year-end 2023.
During the first quarter of 2025, eight insiders acquired approximately $120,034 worth of F & M Bank shares at an average price of $19.73 per share. Currently, the stock trades at $18.90 per share, having lost 5.50% since the beginning of the year. Over the past 12 months, F & M Bank returned 11.37% to its investors.
The analyst coverage on F & M Bank stock is currently limited.
11. Gryphon Digital Mining, Inc. (NASDAQ:GRYP)
Market Cap: $11.36 million
Number of insiders buying: 8
Gryphon operates as a bitcoin mining company in the United States. It operates mining computers and ESG-led mining. The company was founded in 2020 and is based in Las Vegas, Nevada.
In a recent development, Gryphon announced the creation of a strategic Bitcoin reserve program as part of its capital strategy. This move is part of Gryphon’s efforts to strengthen its balance sheet and acquire significant assets, including restructuring $18 million in Bitcoin debt and securing a deal for a scalable HPC/AI asset in Alberta, with potential growth to 4GW.
In January, eight insiders, including the company’s CFO, bought approximately $264,330 worth of Gryphon shares at an average price of $0.39 per share. Year-to-date, the stock is down 59.95% trading at $0.16 per share. Over the past 12 months, Gryphon shares declined 89.03%.
For the third quarter ending September 30, 2024, Gryphon reported mining revenues of $3.7 million, down from $5.2 million in the same quarter of 2023. Adjusted EBITDA for the quarter was a loss of $2.5 million, an improvement from a loss of $4.7 million in Q3 2023. The company posted a net loss of $5.95 million, compared to a net loss of $8.09 million in the third quarter of the previous year. Gryphon’s management will host a conference call on March 31 to discuss results for its fourth quarter and full year ended December 31, 2024.
Currently, the analyst coverage on Gryphon stock remains limited.
10. The Oncology Institute, Inc. (NASDAQ:TOI)
Market Cap: $100.05 million
Number of insiders buying: 8
The Oncology Institute ranks tenth among the 20 stocks that insiders are buying in Q1 2025. It provides medical oncology services in the United States, focusing on adult and senior cancer patients. The company offers a range of services, including physician care, infusion, clinical trials, radiation, and patient support. It also collaborates with Healthy Forge to deliver cancer care services in Southern California.
In a recent development, the company launched the Florida Oncology Network, a fully delegated network aimed at expanding access to high-quality cancer care for Florida residents. The network, which includes TOI Clinics and a panel of oncologists, partners with Provider Network Solutions to enhance care coordination, improve patient outcomes, and expand its reach across the state in 2025.
Dan Virnich, CEO of TOI, stated, “I’m very excited about the launch of Florida Oncology Network and our continued rapid growth in capitated lives in Q1.
For the fourth quarter of 2024, The Oncology Institute reported revenue of $100 million, an increase of 16.9% compared to the prior-year quarter. Gross profit amounted to $15 million, up 1.8% from the same period of 2023. Net loss was $13.2 million, which compares to net loss of $18.8 million in the corresponding quarter of the prior year.
In March, eight insiders, including the company’s CEO, CMO, and COO, acquired a total of around $1.61 million worth of The Oncology Institute shares at an average price of $1.04 per share. Year-to-date the stock is up 277.58% trading at $1.17 per share. However, over the past 12 months, the Oncology Institute shares dropped 24.97%.
Currently, the analyst coverage on The Oncology Institute stock is limited.
9. Zomedica Corp. (OTCQB:ZOMDF)
Market Cap: $56.84 million
Number of insiders buying: 8
Zomedica is a veterinary health company based in Ann Arbor, Michigan. The company specializes in diagnostic and therapeutic products for companion animals, offering solutions like TRUFORMA and TRUVIEW diagnostic platforms, along with PulseVet and Assisi Loop devices for pain and inflammation treatment. Zomedica also works with Celsee, Inc. and Seraph Biosciences, Inc. to develop advanced diagnostic and pathogen detection technologies. It is also one of the 15 cheapest stocks insiders are purchasing in March.
For the full year 2024, Zomedica reported revenue of $27.3 million, up from $25.2 million in 2023. Operating expenses reached $70.1 million, reflecting a full year of costs associated with Qorvo Biotechnologies, compared to $60.6 million the previous year. Research and development expenses increased to $7.3 million from $5.8 million in 2023, while the net loss widened to $47.0 million, compared to a loss of $34.5 million in 2023.
In March, eight insiders, including the company’s CEO, and COO, acquired a total of around $375,385 worth of Zomedica shares at an average price of $0.07 per share. Currently, the stock trades at $0.054 per share, having dropped 55% year-to-date, and 61.43% over the past 12 months.
According to MarketBeat, one analyst rates Zomedica stock as a “Moderate Buy” with a price target of $0.25 per share. The average price target suggests a 362.96% upside from the latest price.
8. Evolent Health, Inc. (NYSE:EVH)
Market Cap: $1.12 billion
Number of insiders buying: 9
The eighth stock among the 20 that insiders were buying the most in the first quarter of the year is Evolent Health, a provider of healthcare plans and benefits management services. Through its subsidiary Evolent Health LLC, it offers specialty care management services in oncology, cardiology, and musculoskeletal markets, focusing on improving patient outcomes and reducing costs. Its integrated platform supports health plan administration and value-based business infrastructure, offering services such as pharmacy benefits management, risk management, analytics, and leadership support. Additionally, Evolent provides Identifi, a proprietary technology system that aggregates data, manages care workflows, and engages patients, as well as Machinify Auth, a software platform utilizing artificial intelligence to optimize care processes. The company is based in Arlington, Virginia,
For the full year 2024, the company reported revenue of $2.55 billion, 30.1% up from $1.96 billion in 2023. The net loss for the year was $93.45 million, an improvement from the $142.26 million loss in 2023. Looking ahead to 2025, Evolent expects revenue between $2.06 billion and $2.11 billion, reflecting an annual growth rate of 15%-18%, excluding the impact of one-time contract changes in three Performance Suite contracts. The company also anticipates adjusted EBITDA in the range of $135 million to $165 million.
In March, nine insiders, including the company’s CEO, purchased a total of around $1.35 million worth of Evolent Health shares at an average price of $9.10 per share. Currently, the stock trades at $9.53 per share, having declined 15.29% year-to-date and 70.15% over the past 12 months.
Fourteen analysts rate Evolent Health stock as “Buy,” according to MarketBeat. The average price target of $17.71 suggests an upside of 85.88% from the latest price.
Evolent Health is also one of the 12 stocks that are about to explode.
7. Juniata Valley Financial Corp. (OTCQX:JUVF)
Market Cap: $62.54 million
Number of insiders buying: 9
Juniata Valley is the parent company of The Juniata Valley Bank, which provides retail and commercial banking services to small and mid-sized businesses in central and northern Pennsylvania. The Mifflintown, Pennsylvania-based bank offers a variety of deposit accounts, loans, and banking services, including mobile deposits, online banking, and trust services.
In February and March, nine insiders, including the CEO, and CFO, purchased a total of $6,641 worth of Juniata Valley shares at an average price of $12.89. Currently, the stock trades at $12.50, having lost 3.99% since the beginning of the year. However, over the past 12 months, its shares returned 5.22%.
For the quarter ended December 31, 2024, Juniata Valley disclosed net income of $1.5 million, which compares to a net income of $1.7 million in the same period of 2023. Earnings per share, basic and diluted, was $0.30, compared to $0.33 for the corresponding quarter of the prior year. For the full year 2024, net income amounted to $6.2 million compared to net income of $6.6 million for 2023.
Currently, the analyst coverage on Juniata Valley stock is limited.
6. Community West Bancshares (NASDAQ:CWBC)
Market Cap: $350.53 million
Number of insiders buying: 10
Community West Bancshares is the parent company of Central Valley Community Bank, offering a range of commercial banking services to businesses and individuals in California. The Fresno, California-headquartered bank provides various deposit products, including demand, savings, and time deposits, as well as loans for businesses, real estate, and consumers. Founded in 1979, the company changed its name from Central Valley Community Bancorp to Community West Bancshares in April 2024.
For the quarter ending December 31, 2024, Community West Bancshares reported unaudited consolidated net income of $6.9 million, or $0.36 per diluted share, compared to $5.89 million, or $0.50 per diluted share, for the same period in the previous year. Additionally, the company declared a cash dividend of $0.12 per common share.
In February and March, 10 insiders acquired a total of around $120,088 worth of Community West Bancshares shares at an average price of $18.22. The stock is now trading at $18.39, having lost 5.06% year-to-date and 7.59% over the past 12 months.
The consensus rating on Community West Bancshares stock from three analysts is “Buy” with a price target of $23.33, reports StockAnalysis. The average price target indicates a potential upside of 26.86%.
5. Isabella Bank Corporation (OTCQX:ISBA)
Market Cap: $174.98 million
Number of insiders buying: 10
Isabella Bank, based in Michigan, is the parent company of Isabella Bank, a state-chartered community bank that has been serving local banking needs since its founding in 1903. With over 120 years of experience, the bank offers a wide range of services, including personal and commercial lending, deposit products, as well as investment, trust, and estate planning services. The stock ranks fifth among 20 stocks that insiders were buying in the first quarter of 2025.
In the first quarter of the year, 10 insiders, including the CEO, and COO, acquired a total of around $101,785 worth of Isabella Bank shares at an average price of $24.73 per share. Currently, the stock trades at $23.60 per share, having lost 8.88%. However, over the past 12 months, Isabella Bank shares gained 20.90%.
For the full year of 2024, Isabella Bank reported net income of $13.9 million, or $1.86 per diluted share, down from $18.2 million, or $2.40 per diluted share in 2023. The bank’s core earnings for 2024, a non-GAAP measure, were $15.0 million, or $2.01 per diluted share, compared to $18.0 million, or $2.37 per diluted share, in 2023.
On February 27, the company’s board of directors declared a first-quarter cash dividend of $0.28 per common share.
One Wall Street analyst rates Isabella Bank stock as “Hold,” with a price target of $28.00, according to TipRanks. The average price target suggests an 18.64% potential upside from the latest price.
4. QNB Corp. (OTCQX:QNBC)
Market Cap: $130.28 million
Number of insiders buying: 10
QNB Corp serves as the bank holding company for QNB Bank, offering a range of commercial, retail banking, and brokerage services. Its deposit products include various demand and savings accounts, such as interest-bearing demand accounts and traditional statement savings, along with securities and advisory services. The company is based in Quakertown, Pennsylvania.
For the fourth quarter of 2024, the company reported net income of $3.05 million, or $0.83 per diluted share, a significant increase from the $1.13 million, or $0.31 per share, reported in the same quarter of 2023. As of December 31, 2024, QNB Corp’s total assets stood at $1.87 billion, up from $1.71 billion a year earlier.
In addition, QNB Corp declared a dividend of $0.37 per share in December 2024.
In January and February, 10 insiders, including the CFO, bought a total of around $156,778 worth of QNB Corp shares at an average price of $34.11 per share. Year-to-date, the stock is up 3.77% trading at $35.20 per share. Over the past 12 months, QNB Corp shares returned 46.97% to its investors.
The analyst coverage on QNB Corp stock is currently limited.
3. Smithfield Foods, Inc. Common Stock (NASDAQ:SFD)
Market Cap: $7.95 billion
Number of insiders buying: 10
Smithfield Foods is a global food company and one of the world’s largest pork processors and hog producers. The Smithfield, Virginia-based company operates both domestically and internationally. Its Packaged Meats segment includes products like bacon, sausage, and hot dogs under brands such as Smithfield, Eckrich, and Nathan’s Famous, while its Fresh Pork segment processes live hogs into various pork cuts for retail, food service, and export markets. The company’s Hog Production segment raises hogs on both owned and contracted farms and also sells grains to external customers.
Smithfield Foods went public in January, and 10 insiders, including the CEO, and CFO, took part in its initial public offering by acquiring a total of $65.68 million worth of shares at a price of $20.00 per share. Since the offering, Smithfield Foods shares gained 2.43%, trading at $20.23 per share.
For the fiscal year 2024, the company disclosed net sales of $14.14 billion, compared to $14.64 billion in 2023. Operating profit was $1.12 billion, which compares to an operating loss of $56 million in the prior year. As of December 29, 2024, the company had $3.25 billion of available liquidity consisting of $943 million in cash and cash equivalents and $2,303 million of availability under its committed credit facilities. Smithfield Foods generated $916 million in cash flows from operating activities and ended the fiscal year 2024 with a net debt to Adjusted EBITDA ratio of 0.8x.
On March 24, the company’s board declared a quarterly cash dividend of $0.25 per share of common stock.
For the fiscal 2025, Smithfield Foods projects adjusted operating profit of between $1.10 billion to $1.30 billion and total sales to increase in the low-to-mid-single-digit percent range compared to fiscal year 2024.
In a recent development, the company announced it has been added to the Russell 1000 Index, a key benchmark for large-cap U.S. stocks.
Based on the estimates of five analysts, Smithfield Food stock has an average rating of “Strong Buy,” reports StockAnalysis. The 12-month price target is $28.60, reflecting a potential upside of 41.37% from the latest price.
2. Matador Resources Company (NYSE:MTDR)
Market Cap: $6.32 billion
Number of insiders buying: 15
Matador Resources Company is engaged in the acquisition, exploration, development, and production of oil and natural gas resources across the United States. The Dallas, Texas-based company operates in two segments: Exploration and Production, and Midstream. Matador is also one of the 7 best cheap energy stocks to invest in now.
During the first quarter, 15 insiders, including the CEO, and COO, bought around $1.58 million worth of Matador shares at an average price of $59.97 per share. Over the past 12 months, Matador stock lost 10.22% year-to-date and 25.5% over the past 12 months. Currently, it trades at $50.51 per share.
For the full year 2024, Matador reported a record average daily production of 170,751 BOE (barrels of oil equivalent). The company’s net income reached $885.3 million, or $7.14 per diluted share, up from $846.1 million, or $7.05 per diluted share, in 2023. Revenue for the year totaled $3.50 billion, a significant increase from the $2.81 billion reported in the previous year.
Based on 15 Wall Street analysts’ estimates, Matador stock is a “Strong Buy,” with a price target of $73.93 per share, reports TipRanks. The average price target suggests a 46.37% increase from the latest price.
1. Eagle Financial Services, Inc. (NASDAQ:EFSI)
Market Cap: $175.42 million
Number of insiders buying: 21
Eagle Financial, the parent company of Bank of Clarke, ranks first among the 20 stocks insiders were buying in the first quarter of 2025. The bank offers a wide range of retail and commercial banking products and services, operating across three primary divisions: Community Banking, Marine Lending, and Wealth Management.
Its commercial banking activities include attracting deposits from customers and using those funds to provide commercial, consumer, and real estate loans, as well as investing in corporate, municipal, and U.S. government securities. Deposits at the bank are insured by the Federal Deposit Insurance Corporation (FDIC), subject to legal limits.
On January 22, 2025, Eagle Financial’s board declared a quarterly cash dividend of $0.31 per common share.
During the first quarter, 21 insiders acquired a total of $506,720 worth of Eagle Financial shares at an average price of $32.00 per share. These acquisitions were part of the company’s underwritten public offering of 1,562,500 common shares. Eagle Financial said at the time it planned to use the net proceeds from this offering for general corporate purposes, which may include balance sheet restructuring and supporting its capital ratios and growth.
Year-to-date, the stock is down 9.86%, trading at $32.81 per share. However, over the last 12 months, Eagle Financial shares returned 10.96% to its investors.
For the fourth quarter of 2024, Eagle Financial reported a net income of $6.2 million, up from $3.4 million in the previous quarter. Sales were $18.6 million and $7.4 million in mortgage and SBA loans, respectively, with a gain on sales of $861,000. Earnings per share increased by $0.77 for the quarter to $1.74.
According to StockAnalysis, two analysts rate Eagle Financial as “Strong Buy,” with a 12 month price target of $40.00, representing a 21.91% upside from the latest price.
Overall, EFSI is first among the 20 stocks insiders were buying in Q1 2025. While we acknowledge the potential of EFSI our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than EFSI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
